Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Inflammation for Endometrial Cancer Prevention

NCT05407025 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05407025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05407025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Inflammation for Endometrial Cancer Prevention
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Active, not recruiting
Start date
December 1, 2021
Completion date
December 31, 2027
Enrollment
191 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial carcinoma